-- Curaleaf Holdings (CURA.TO), which rose by more than 8% yesterday, on Thursday said the Toronto Stock Exchange (TSX) approved the company to start a normal course issuer bid (NCIB).
The bid will allow the company to buy back up to near 34.4-million of its subordinate voting shares over the 12-month period starting on Apr. 20, 2026 and ending no later than Apr. 19, 2027, representing about 5% of the subordinate voting shares issued and outstanding as of Apr. 10, 2026, or an aggregate fair market value of about US$83 million based on the closing trading price of the subordinate voting shares on the TSX on Apr. 14, 2026.
As of Apr. 10, there were 687.8-million subordinate voting shares issued and outstanding.
"This share repurchase program is a meaningful way to return value to our shareholders and reflects our confidence in the strength and durability of our strategy," said Boris Jordan, Chairman and CEO.
Shares of the company closed up $0.28 to $3.60 on Wednesday on the TSX.